Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.53 |
| ▸ | CA12 | O43570 | 1/20 | 0.50 |
| ▸ | CA1 | P00915 | 1/20 | 0.50 |
| ▸ | CA2 | P00918 | 1/20 | 0.50 |
| ▸ | CA7 | P43166 | 1/20 | 0.50 |
| ▸ | CA9 | Q16790 | 1/20 | 0.50 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.50 |
| ▸ | CYP1A2 | P05177 | 8/20 | 0.45 |
| ▸ | CYP3A4 | P08684 | 6/20 | 0.45 |
| ▸ | CYP1A1 | P04798 | 7/20 | 0.43 |
| ▸ | CYP1B1 | Q16678 | 7/20 | 0.43 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.42 |
| ▸ | USP2 | O75604 | 1/20 | 0.42 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.42 |
| ▸ | ERN1 | O75460 | 1/20 | 0.42 |
| ▸ | ABCG2 | Q9UNQ0 | 2/20 | 0.41 |
| ▸ | CYP2C19 | P33261 | 3/20 | 0.39 |
| ▸ | CYP2E1 | P05181 | 2/20 | 0.39 |
| ▸ | CYP2C8 | P10632 | 2/20 | 0.39 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Difucol Hexamethyl Ether SCHEMBL505203 | 0.77 | CYP1A2 (0.60) | ALDH1A1CA12CA1CA2CA7 | |
| SCHEMBL686849 | 0.74 | CYP1A2 (0.64) | ALDH1A1CA12CA1CA2CA7 | |
| SCHEMBL862161 | 0.74 | ALDH1A1 (0.56) | ALDH1A1CA12CA1CA2CA7 | |
| SCHEMBL504691 | 0.72 | ALDH1A1 (0.53) | ALDH1A1CA12CA1CA2CA7 | |
| SCHEMBL1402593 | 0.72 | ALDH1A1 (0.53) | ALDH1A1CA12CA1CA2CA7 | |
| SCHEMBL2091704 | 0.72 | ALDH1A1 (0.53) | ALDH1A1CA12CA1CA2CA7 | |
| SCHEMBL2028309 | 0.72 | ALDH1A1 (0.53) | ALDH1A1CA12CA1CA2CA7 | |
| SCHEMBL12581396 | 0.72 | ALDH1A1 (0.53) | ALDH1A1CA12CA1CA2CA7 | |
| SCHEMBL15883267 | 0.72 | ALDH1A1 (0.53) | ALDH1A1CA12CA1CA2CA7 | |
| SCHEMBL2093672 | 0.72 | ALDH1A1 (0.53) | ALDH1A1CA12CA1CA2CA7 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 23 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12473252-B2 | Processes for the preparation of deuterated D-serine | SUN PHARMACEUTICAL INDUSTRIES, INC. (US) | 2025-11-18 | — | — | US | claimed |
| US-20250042841-A1 | PROCESSES FOR THE PREPARATION OF DEUTERATED D-SERINE | SUN PHARMACEUTICAL INDUSTRIES, INC. | 2025-02-06 | — | — | US | claimed |
| US-12065395-B2 | Processes for the preparation of deuterated D-serine | SUN PHARMACEUTICAL INDUSTRIES, INC. (US) | 2024-08-20 | — | — | US | claimed |
| US-20220169595-A1 | PROCESSES FOR THE PREPARATION OF DEUTERATED D-SERINE | SUN PHARMACEUTICAL INDUSTRIES, INC. | 2022-06-02 | — | — | US | claimed |
| WO-2020206367-A1 | PROCESSES FOR THE PREPARATION OF DEUTERATED D-SERINE | CONCERT PHARMACEUTICALS, INC. (US) | 2020-10-08 | — | — | WO | claimed |
| JP-60038375-A | — | — | None | — | — | JP | disclosed |
| US-12473252-B2 | Processes for the preparation of deuterated D-serine | SUN PHARMACEUTICAL INDUSTRIES, INC. (US) | 2025-11-18 | — | — | US | disclosed |
| US-20250042841-A1 | PROCESSES FOR THE PREPARATION OF DEUTERATED D-SERINE | SUN PHARMACEUTICAL INDUSTRIES, INC. | 2025-02-06 | — | — | US | disclosed |
| WO-2024184177-A1 | CATIONIC COMPOUNDS FOR ANION EXCHANGE MEMBRANES | AGFA-GEVAERT NV (BE) | 2024-09-12 | — | — | WO | disclosed |
| EP-4424665-A1 | CATIONIC COMPOUNDS FOR ANION EXCHANGE MEMBRANES | AGFA-GEVAERT NV (BE) | 2024-09-04 | — | — | EP | disclosed |
| US-12065395-B2 | Processes for the preparation of deuterated D-serine | SUN PHARMACEUTICAL INDUSTRIES, INC. (US) | 2024-08-20 | — | — | US | disclosed |
| US-20220169595-A1 | PROCESSES FOR THE PREPARATION OF DEUTERATED D-SERINE | SUN PHARMACEUTICAL INDUSTRIES, INC. | 2022-06-02 | — | — | US | disclosed |
| US-7126014-B2 | Synthesis of epecatechin-4α, 8-epicatechin and -catechin dimers and derivatives thereof | MARS, INC. | 2006-10-24 | — | — | US | disclosed |
| US-20050014958-A1 | Synthesis of 4alpha-arylepicatechins | MARS, INCORPORATED | 2005-01-20 | — | — | US | disclosed |
| US-6720432-B2 | OXIDIZING HYDROXYL-PROTECTED BENZYLEPITCATECHIN, ADDING NUCLEOPHILIC ARYL-ORGANOMETALLIC REAGENT, AND DEOXYGENATING FORMING COMPOUNDS SUCH AS 3,5,7,3',4'-PENTA-O-BENZYL-4-HYDROXYEPICATECHIN; PROCYANIDINS | MARS INCORPORATED | 2004-04-13 | — | — | US | disclosed |
| EP-1317437-A2 | SYNTHESIS OF 4-ALPHA-ARYLEPICATECHINS | Mars Incorporated (US) | 2003-06-11 | — | — | EP | disclosed |
| US-20030100775-A1 | Synthesis of 4alpha-arylepicatechins | MARS INCORPORATED | 2003-05-29 | — | — | US | disclosed |
| US-6476241-B1 | Synthesis of 4α-arylepicatechins | MARS INCORPORATED | 2002-11-05 | — | — | US | disclosed |
| WO-2002020506-A2 | SYNTHESIS OF 4α-ARYLEPICATECHINS | MARS, INCORPORATED (US) | 2002-03-14 | — | — | WO | disclosed |
| JP-S6038375-A | PREPARATION OF KETONE | NIPPON SHINYAKU CO LTD | 1985-02-27 | — | — | JP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030100775-A1 | Synthesis of 4alpha-arylepicatechins | FABP4, TEAD4, FABP7 | ALDH1A1 617/4885CA12 4189/4885CA1 3986/4885 |
| US-20050014958-A1 | Synthesis of 4alpha-arylepicatechins | FABP7, FABP4, TEAD4 | ALDH1A1 643/4885CA12 4146/4885CA1 3953/4885 |
| US-12473252-B2 | Processes for the preparation of deuterated D-serine | PSPH, SRR, DHPS | ALDH1A1 3327/4885CA12 3882/4885CA1 2016/4885 |
| US-12065395-B2 | Processes for the preparation of deuterated D-serine | PSPH, SRR, DHPS | ALDH1A1 3327/4885CA12 3882/4885CA1 2016/4885 |
| US-20220169595-A1 | PROCESSES FOR THE PREPARATION OF DEUTERATED D-SERINE | PSPH, SRR, DHPS | ALDH1A1 3327/4885CA12 3882/4885CA1 2016/4885 |
| US-20250042841-A1 | PROCESSES FOR THE PREPARATION OF DEUTERATED D-SERINE | PSPH, SRR, DHPS | ALDH1A1 3327/4885CA12 3882/4885CA1 2016/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.